Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Microbiological conclusions.

× No keyword cloud information.

10 in total

1. Clinical trials of cefpodoxime proxetil suspension in paediatrics.

Authors: R Fujii
Journal: Drugs Date: 1991 Impact factor: 9.546

Review 2. A review of the pharmacokinetics of cefpodoxime proxetil.

Authors: M T Borin
Journal: Drugs Date: 1991 Impact factor: 9.546

3. Cefpodoxime proxetil in the treatment of skin and soft tissue infections.

Authors: K J Tack; N E Wilks; G Semerdjian; C H Frazier; K Shirin; A Puopolo; S G Crossland; B S Goffe; L Millikan
Journal: Drugs Date: 1991 Impact factor: 9.546

4. Microbiological evaluation of cefpodoxime proxetil.

Authors: B Wiedemann; E Luhmer; M T Zühlsdorf
Journal: Drugs Date: 1991 Impact factor: 9.546

Review 5. The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors: M H Richmond; R B Sykes
Journal: Adv Microb Physiol Date: 1973 Impact factor: 3.517

6. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.

Authors: Y Utsui; M Inoue; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1987-07 Impact factor: 5.191

7. Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807).

Authors: R N Jones; A L Barry
Journal: Antimicrob Agents Chemother Date: 1988-04 Impact factor: 5.191

8. Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.

Authors: R N Jones; A L Barry; M Pfaller; S D Allen; L W Ayers; P C Fuchs
Journal: Diagn Microbiol Infect Dis Date: 1988-01 Impact factor: 2.803

9. In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition.

Authors: R N Jones; A L Barry
Journal: Diagn Microbiol Infect Dis Date: 1987-12 Impact factor: 2.803

10. Studies on orally active cephalosporin esters.

Authors: K Fujimoto; S Ishihara; H Yanagisawa; J Ide; E Nakayama; H Nakao; S Sugawara; M Iwata
Journal: J Antibiot (Tokyo) Date: 1987-03 Impact factor: 2.649

10 in total